HB Wealth Management’s Insmed INSM Stock Holding History

HB Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,786	Closed	-$292K	–	1763
2026 Q1	$292K	Buy	1,786 +468	+36%	+$72K	﹤0.01%	1250
2025 Q4	$229K	Buy	+1,318	New	+$241K	﹤0.01%	1276

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

HB Wealth Management's INSM Position: Q2 2026 in Review

HB Wealth Management sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,786 shares — an estimated $292K sold.

HB Wealth Management first reported a position in INSM in Q4 2025 and held it in 2 quarters. The position peaked at $292K in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

HB Wealth Management reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
HB Wealth Management sold 1,786 Insmed shares in Q2 2026, an estimated $292K.
HB Wealth Management first reported a position in Insmed in Q4 2025 and held it in 2 quarters.
HB Wealth Management's Insmed position peaked at $292K in Q1 2026.
663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.